About Intermediate filament family orphan 2
Intermediate filament family orphan 2 (IFFO2) is a protein
from Homo sapiens identified by UniProt accession
Q5TF58, 517 residues long.
MolForge cross-references it against 0 known binders and
13 disease associations.
Target properties
| Protein name | Intermediate filament family orphan 2 |
| UniProt accession | Q5TF58 |
| Gene | IFFO2 |
| Organism | Homo sapiens |
| Length | 517 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (13)
Diseases linked to this target (Open Targets).
- brain measurement · score 0.29
- plasminogen activator inhibitor 1 measurement · score 0.13
- metabolite measurement · score 0.03
- breast carcinoma · score 0.02
- dysplasia · score 0.01
- nasopharyngeal neoplasm · score 0.00
- neoplasm · score 0.00
- eosinophilic esophagitis · score 0.00
- myeloid sarcoma · score 0.00
- liver hemangioma · score 0.00
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q5TF58-F1 | alphafold | PREDICTED | 68.05 | — |
Amino-acid sequence (517 residues)
MVNSLLFGEM ALAFGCPPGG GGGGCPGGGG GGGGAGPGPS PVTAALRDDL GSNIHLLKGL NVRFRCFLAK VHELERRNRL LEKQLEQQQS ERERRLRYKT FSREQAVQTG PELLRPPAPG GGHGLSSGAA AGANANAVAL GGLPPGGGSH PQHYGRLPGT IWSYTQVRRT GGGGVETVQG PGVSWVHPDG VGVQIDTITP EIRALYNVLA KVKRERDEYK RRWEEELAKR MNLQTMVDTL QEAAQEADAI QEEMNEKIER LKAELVVFKG LMSDPMTDLD TKIQEKAMKV DMDICRRIDI TAKLCDVAQQ RNSEDVSKIF QVVPKKKERK VASDDDISEQ DGEVNRFSDD EVGSMNITDE MKRMFNQLRE TFDFDDDCDS LTWEENEDTL LLWEDFTNCN PTIDLQGEQE ENLGNLIHET ESFFKTRDKE YQETIGQIEL ELATAKSDMN RHLHEYMEMC SMKRGLDVQM ETCRRLIKGS ADRNSPSPSS VASSDSGSTD EIQDEFEREA DVEPMVS
Explore Intermediate filament family orphan 2 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets